{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:38:14Z","timestamp":1789749494997,"version":"4.0.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03332-2","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T15:02:39Z","timestamp":1724079759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Use of biologic therapies in the management of pyoderma gangrenosum: a systematic review"],"prefix":"10.1007","volume":"316","author":[{"given":"Michele","family":"Zaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omkar","family":"Mayur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Serwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"McNichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean S.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"issue":"4","key":"3332_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","volume":"62","author":"J Miller","year":"2010","unstructured":"Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR (2010) Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol 62(4):646\u2013654","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3332_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/gut.2005.074815","volume":"55","author":"TN Brooklyn","year":"2006","unstructured":"Brooklyn TN, Dunnill MGS, Shetty A, Bowden JJ, Williams JD, Griffiths CE, Probert C (2006) Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 55(4):505\u2013509","journal-title":"Gut"},{"key":"3332_CR3","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1007\/s10620-013-2762-2","volume":"58","author":"F Arg\u00fcelles-Arias","year":"2013","unstructured":"Arg\u00fcelles-Arias F, Castro-Laria L, Lobat\u00f3n T, Aguas-Peris M, Rojas-Feria M, Barreiro-de Acosta M, Herrer\u00edas-Guti\u00e9rrez JM (2013) Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci 58:2949\u20132954","journal-title":"Dig Dis Sci"},{"key":"3332_CR4","doi-asserted-by":"crossref","unstructured":"Ormerod, A. D., Thomas, K. S., Craig, F. E., Mitchell, E., Greenlaw, N., Norrie, J.,\u2026 Williams, H. C. (2015). Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. bmj, 350","DOI":"10.1136\/bmj.h2958"},{"issue":"6","key":"3332_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/apt.12431","volume":"38","author":"A Agarwal","year":"2013","unstructured":"Agarwal A, Andrews JM (2013) Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy. Aliment Pharmacol Ther 38(6):563\u2013572","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"3332_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","volume":"19","author":"C George","year":"2019","unstructured":"George C, Deroide F, Rustin M (2019) Pyoderma gangrenosum\u2013a guide to diagnosis and management. Clin Med 19(3):224","journal-title":"Clin Med"},{"issue":"5","key":"3332_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/iwj.13389","volume":"17","author":"MM Hobbs","year":"2020","unstructured":"Hobbs MM, Ortega-Loayza AG (2020) Pyoderma gangrenosum: from historical perspectives to emerging investigations. Int Wound J 17(5):1255\u20131265","journal-title":"Int Wound J"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03332-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03332-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03332-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:07:00Z","timestamp":1729699620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03332-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":7,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["3332"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03332-2","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Authors report no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"539"}}